ELUTIA INC (ELUT)
(Delayed Data from NSDQ)
$3.19 USD
-0.01 (-0.31%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $3.16 -0.03 (-0.94%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ELUT 3.19 -0.01(-0.31%)
Will ELUT be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for ELUT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELUT
Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus
ELUT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights BRC, Costamare and Elutia
3 Best Breakout Stocks Worth a Buy for Attractive Returns
Elutia Inc. (ELUT) Upgraded to Buy: Here's Why
Other News for ELUT
SWK Holdings Provides Portfolio Update
SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc
Lake Street Sticks to Their Buy Rating for Aziyo Biologics (ELUT)
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro?, Company?s Antibiotic-Eluting BioEnvelope for Implantable Devices
Elutia announces new peer reviewed publication on EluPro